Both scientists believe these findings may open new doors for regenerative medicine
As clinical research continues and protocols are optimized, we'll likely see: More large-scale, placebo-controlled human trials Better understanding of optimal dosing and timing Combined protocols with stem cells or PRP Integration into mainstream sports medicine and orthopedic practice Potential FDA approval (currently in preclinical/early clinical stage) For now, BPC-157 remains a biohacker's and athlete's best tool for accelerating tendon recoverywith a solid foundation of animal evidence and growing human case studies
Sajikumar and Korte, 2011
Nitrous oxide-induced B deficiency myelopathy: perspectives on the clinical biochemistry of vitamin B
From tissue repair to anti-inflammatory effects, this peptide seems to hold the key to accelerated recovery and enhanced well-being
However, Cagrilintide failed to induce significant cFos activation in RAMP1/3 KO mice, whereas sCT retained its ability to do so, likely via residual AMY2R signaling